Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Comino is an international start-up specialising in the design and production of liquid-cooled PCs and servers. It claims that its products consume up to 40% less electricity than equivalent air-cooling computers. The company currently operates in AI, Forensic, Gaming, and Video Rendering, with aspirations to enter other domains in the coming years. Comino has sold 2,000 work stations to professional businesses, accruing sales north of 9 million EUR since its launch in 2017. Its products have been accredited by global hardware giants like AMD and ASUS. The company will use 70% of proceeds for manufacturing its devices, 10% towards marketing and promotional materials, and 20% to compensate its teams.
days to go:
Expired
investment:
£949,608
Elemental Digest is a clean-tech Agri-Food technology manufacturing business that transforms the industrial waste problem into high value-added sustainable products with impressive economic, nutritional, and environmental benefits. The company recovers valuable food extracts and creates organic 'clean' phosphate-rich fertiliser for soil and crop enhancement. These products are tested and validated by Rothamsted Research. Elemental Digest is partnered with a well-known leading international meat producer. It has qualified its final products and is ready to produce to scale. The raised funds will be used in building the fertiliser plant, developing the team, expanding markets, and research & development to qualify crop-related precision applications.
days to go:
Expired
investment:
£1,525,240
Spendology is a fintech company that licenses a digital-first SaaS-based travel money platform to retailers globally, addressing the demand for travel cash, which remains popular among Brits, with over £56 billion spent annually. Inspired by the inconvenience of traditional currency exchange services, the company's chairman, Don Clark, aims to revolutionize the industry, much like he did in a previous financial services venture that resulted in a significant sale. Spendology's innovative platform allows travel companies to offer online ordering and home delivery of travel cash, generating additional profits for these businesses and royalties for Spendology. Their platform is available to travel companies of all sizes worldwide, already operating in the UK and launching in the US, with plans to expand to 28 countries, serving a market worth $1 trillion.
days to go:
Expired
investment:
£354,053
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
days to go:
Expired
investment:
£894,056
